Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
11 Results for "
human teratocarcinoma
" in MedChemExpress (MCE) Product Catalog:
Products (11)
11 Results for "human teratocarcinoma" in MCE Product Catalog:
2
2 Cited Publications
Target:
Research Areas:
CBB1007 trihydrochloride is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 trihydrochloride significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 trihydrochloride shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 trihydrochloride is studied in non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
Cat. No.: HY-156209
CAS No.: 137896-85-6
Target:
Research Areas:
Gb3 (d18:1/16:0) (Compound 1) is the P k antigen of the P blood group system. Gb3 (d18:1/16:0) acts as a cell surface receptor. Gb3 (d18:1/16:0) is used for research on Burkitt's lymphoma, teratocarcinoma, embryonal carcinoma, and Fabry's disease .
Cat. No.: HY-15313
CAS No.: 1379573-92-8
Target:
Research Areas:
CBB1007 is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 is studied in non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
Target:
Research Areas:
CBB1007 hydrochloride is a reversible and selective LSD1 inhibitor with an IC50 of 5.27 µM for human LSD1. CBB1007 hydrochloride significantly blocks the demethylase activity of LSD1 on H3K4Me2 and H3K4Me. CBB1007 hydrochloride shows selectivity for LSD1 over LSD2 or JARID1A, and induces differentiation-related genes in pluripotent cells. CBB1007 hydrochloride is studied in non-pluripotent cancer research, targeting teratocarcinoma, embryonic carcinoma, and seminoma .
Cat. No.: HY-P700489
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO3; teratocarcinoma-Derived Growth Factor 3; Prev. TDGF1P3; Protein CRIPTO3; Prev. TDGF3; teratocarcinoma-Derived Growth Factor 2 (Retroposin, Possibly Expressed); CRIPTO-3; teratocarcinoma-Derived Growth Factor 3, Pseudogene; TDGF2; Putative Teratoc
Species:
Human
Source:
P. pastoris
Cat. No.: HY-P701974
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RRAS2; Ras-Related Protein R-Ras2; RAS Related 2; teratocarcinoma Oncogene; TC21; Ras-Like Protein TC21; Related RAS Viral (R-Ras) Oncogene Homolog 2; NS12
Species:
Human
Source:
E. coli
Cat. No.: HY-114178
CAS No.: 1879980-97-8
Target:
Research Areas:
CDK8-IN-2 is an orally active CDK8 inhibitor of an IC50 values of 0.010 μM. CDK8-IN-2 shows a CDK19 IC50 value of 0.026 μM. CDK8-IN-2 inhibits phospho-STAT1, a pharmacodynamic biomarker of CDK8. CDK8-IN-2 inhibits WNT pathway activity. CDK8-IN-2 can be used for the research of colorectal carcinoma .
Cat. No.: HY-P701975
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RRAS2; Ras-Related Protein R-Ras2; RAS Related 2; teratocarcinoma Oncogene; TC21; Ras-Like Protein TC21; Related RAS Viral (R-Ras) Oncogene Homolog 2; NS12
Species:
Human
Source:
E. coli
Cat. No.: HY-P700481
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:
Human
Source:
E. coli
Cat. No.: HY-P71112
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:
Human
Source:
HEK293
Cat. No.: HY-P703895
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CRIPTO; Cripto-1 Growth Factor; Prev. TDGF1; Cripto-1; teratocarcinoma-Derived Growth Factor 1; CRGF; CR-1; Growth Factor; CR; CRIPTO-1; Epidermal Growth Factor-Like Cripto Protein CR1; Cripto, EGF-CFC Family Member; Protein Cripto
Species:
Human
Source:
HEK293
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
